共 201 条
- [1] Martin ES(2007)Common and distinct genomic events in sporadic colorectal cancer and diverse cancer types Cancer Res 67 10736-10743
- [2] Tonon G(2005)Treatment strategy for patients with colorectal cancer and synchronous irresectable liver metastases Br J Surg 92 1155-1160
- [3] Sinha R(2007)Asymptomatic colorectal cancer with un-resectable liver metastases: immediate colorectal resection or up-front systemic chemotherapy? Ann Surg Oncol 14 766-770
- [4] Xiao Y(2000)Palliative chemotherapy for advanced colorectal cancer: systematic review and meta-analysis. Colorectal Cancer Collaborative Group BMJ 321 531-535
- [5] Feng B(2008)Advances in chemotherapy against advanced or metastatic colorectal cancer Digestion 77 13-22
- [6] Kimmelman AC(2008)Importance of response to neoadjuvant chemotherapy in potentially curable colorectal cancer liver metastases BMC Cancer 8 120-127
- [7] Protopopov A(2008)Irinotecan/fluorouracil combination in first-line therapy of older and younger patients with metastatic colorectal cancer: combined analysis of 2,691 patients in randomized controlled trials J Clin Oncol 26 1443-1451
- [8] Ivanova E(2007)Front-line bevacizumab in combination with oxaliplatin, leucovorin and 5-fluorouracil (FOLFOX) in patients with metastatic colorectal cancer: a multicenter phase II study BMC Cancer 7 91-758
- [9] Brennan C(2007)First clinical experience of orally active epidermal growth factor receptor inhibitor combined with simplified FOLFOX6 as first-line treatment for metastatic colorectal cancer Cancer 110 752-3815
- [10] Montgomery K(2007)Metastatic colorectal cancer-past, progress and future World J Gastroenterol 13 3806-2005